Imperial’s COVID-19 vaccine

Latest news

Imperial College London and Imperial Consultants sign partnership agreement with City Proton

Imperial College London and Imperial Consultants sign partnership agreement with City Proton

The partnership was signed last week at Imperial with representatives from Imperial’s research team, City Proton including Ken Anderson, Chairman, Imperial Consultants and Imperial Innovations, as well as Professor James Stirling, Provost of Imperial College London. read more

Imperial’s new COVID-19 testing lab goes live

Imperial’s new COVID-19 testing lab goes live

Imperial’s contribution to the Testing Alliance launched. Includes the UKAS accredited Molecular Diagnostic Unit (MDU) and existing high-throughput robotic platform for RNA extraction. read more

Power system flexibility is keeping Great Britain’s lights on

Power system flexibility is keeping Great Britain’s lights on

Maintaining flexible power systems able to rapidly respond to changes on the grid is critical in preventing power cuts as Britain transitions to a net zero economy according to Electric Insights report by Dr Iain Staffell and Drax read more

Related case studies

Putting science into Sci-Fi

Putting science into Sci-Fi

When Left Bank Pictures (producers of The Crown and Lost) were looking for someone to give their Sci fi adventure, ORIGIN, a touch of realism - they called upon Imperial Consultants. Thanks to his previous work with filmmakers, writers and artists, they were introduced to Dr Roberto Trotta, a theoretical cosmologist renowned for taking on the unusual - and gifted in translating ‘science-speak’ into layman’s terms. read more

Structures under extreme loading

Structures under extreme loading

The consultants shared their expertise in seismic assessment and design to support the development of EN1998, also known as Eurocode 8. read more

Hepatitis C genotype and drug resistance testing

Hepatitis C genotype and drug resistance testing

Genotype and resistance testing for new direct-acting antiviral (DAA) drugs designed to treat Hepatitis C virus (HCV). read more